David Hsieh, Eric Xueyu Chen, Joseph Wang Franses, Lynn G. Feun, Zishuo Ian Hu, Gentry Teng King, Jimmy J. Hwang, David D. Stenehjem, Casey Cunningham, Daneng Li. "Tegavivint, a downstream Wnt/β-catenin inhibitor: Dose-finding results from a phase 1/2 trial in advanced hepatocellular carcinoma (aHCC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4015